1-7 of 7
vitamin k antagonists
Close
Sort by
Journal Articles

ASH, ABHH, ACHO, Grupo CAHT, Grupo  CLAHT, SAH, SBHH, SHU, SOCHIHEM, SOMETH, Sociedad Panameña de Hematología, SPH, and SVH 2021 guidelines for management of venous thromboembolism in Latin America

Ignacio Neumann, Ariel Izcovich, Ricardo Aguilar, Guillermo León Basantes, Patricia Casais, Cecilia C. Colorio, María Cecilia Guillermo Esposito, Pedro P. García Lázaro, Luis A. Meillon-García, Jaime Pereira, Suely Meireles Rezende, Juan Carlos Serrano, Mario L. Tejerina Valle, Felipe Vera, Lorena Karzulovic, Gabriel Rada, Holger Schünemann
Journal: Blood Advances
Blood Adv (2021) 5 (15): 3032–3046.
https://doi.org/10.1182/bloodadvances.2021004267
Published: 2021
Includes: Supplemental data
Journal Articles

Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry

Clinical Trials & Observations
Jean-Pierre Bassand, Saverio Virdone, Marc Badoz, Freek W. A. Verheugt, A. John Camm, Frank Cools, Keith A. A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, Frank Misselwitz, Karen S. Pieper, Alexander G. G. Turpie, Martin van Eickels, Ajay K. Kakkar
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1081–1091.
https://doi.org/10.1182/bloodadvances.2020003560
Published: 2021
Includes: Supplemental data
Journal Articles

Pharmacometric modeling to explore 4F-PCC dosing strategies for VKA reversal in patients with INR below 2

Clinical Trials & Observations
Ravi Sarode, Katsuyuki Fukutake, Masahiro Yasaka, Michael A. Tortorici, Antoinette Mangione, Marc Pfister, Adam Cuker
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4208–4216.
https://doi.org/10.1182/bloodadvances.2020002267
Published: 2020
Includes: Supplemental data
Journal Articles

Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis

Clinical Trials & Observations
Rasha Khatib, Maja Ludwikowska, Daniel M. Witt, Jack Ansell, Nathan P. Clark, Anne Holbrook, Wojtek Wiercioch, Holger Schünemann, Robby Nieuwlaat
Journal: Blood Advances
Blood Adv (2019) 3 (5): 789–796.
https://doi.org/10.1182/bloodadvances.2018025163
Published: 2019
Includes: Supplemental data
Journal Articles

Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin

Clinical Trials & Observations
Romy M. W. Kremers, Stéphane Zuily, Hilde Kelchtermans, Tessa C. Peters, Saartje Bloemen, Véronique Regnault, H. Coenraad Hemker, Philip G. de Groot, Denis Wahl, Bas de Laat
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1315–1324.
https://doi.org/10.1182/bloodadvances.2018018036
Published: 2018
Includes: Supplemental data
Journal Articles

Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy

Clinical Trials & Observations
William G. Jackson, Clara Oromendia, Ozan Unlu, Doruk Erkan, Maria T. DeSancho
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2320–2324.
https://doi.org/10.1182/bloodadvances.2017008185
Published: 2017
Journal Articles

Multiplexed targeted proteomic assay to assess coagulation factor concentrations and thrombosis-associated cancer

Yassene Mohammed, Bart J. van Vlijmen, Juncong Yang, Andrew J. Percy, Magnus Palmblad, Christoph H. Borchers, Frits R. Rosendaal
Journal: Blood Advances
Blood Adv (2017) 1 (15): 1080–1087.
https://doi.org/10.1182/bloodadvances.2017007955
Published: 2017
Includes: Supplemental data